nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—SLC6A3—bipolar disorder	0.239	0.31	CbGaD
Maprotiline—HTR2C—bipolar disorder	0.216	0.28	CbGaD
Maprotiline—DRD2—bipolar disorder	0.178	0.231	CbGaD
Maprotiline—HTR2A—bipolar disorder	0.137	0.178	CbGaD
Maprotiline—SLC6A2—locus ceruleus—bipolar disorder	0.00756	0.0916	CbGeAlD
Maprotiline—HTR7—locus ceruleus—bipolar disorder	0.00729	0.0883	CbGeAlD
Maprotiline—ORM1—saliva—bipolar disorder	0.00523	0.0634	CbGeAlD
Maprotiline—HTR2A—locus ceruleus—bipolar disorder	0.00455	0.0551	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—bipolar disorder	0.00444	0.0539	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—bipolar disorder	0.0043	0.0521	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—bipolar disorder	0.00402	0.0487	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—bipolar disorder	0.00387	0.0469	CbGeAlD
Maprotiline—HTR7—telencephalic ventricle—bipolar disorder	0.00346	0.0419	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—bipolar disorder	0.00327	0.0396	CbGeAlD
Maprotiline—CYP1A2—urine—bipolar disorder	0.00252	0.0305	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—bipolar disorder	0.00242	0.0293	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—bipolar disorder	0.00216	0.0261	CbGeAlD
Maprotiline—HTR2A—urine—bipolar disorder	0.00197	0.0239	CbGeAlD
Maprotiline—CYP2D6—urine—bipolar disorder	0.00179	0.0217	CbGeAlD
Maprotiline—HTR7—blood plasma—bipolar disorder	0.00165	0.02	CbGeAlD
Maprotiline—CYP1A2—blood plasma—bipolar disorder	0.00131	0.0159	CbGeAlD
Maprotiline—CHRM4—nervous system—bipolar disorder	0.00118	0.0143	CbGeAlD
Maprotiline—Sertraline—MAOA—bipolar disorder	0.00114	0.166	CrCbGaD
Maprotiline—HTR2A—blood plasma—bipolar disorder	0.00103	0.0124	CbGeAlD
Maprotiline—Sertraline—SLC6A3—bipolar disorder	0.000982	0.143	CrCbGaD
Maprotiline—CYP2D6—blood plasma—bipolar disorder	0.000936	0.0113	CbGeAlD
Maprotiline—CHRM5—nervous system—bipolar disorder	0.000921	0.0112	CbGeAlD
Maprotiline—CHRM4—brain—bipolar disorder	0.0009	0.0109	CbGeAlD
Maprotiline—Sertraline—SLC6A4—bipolar disorder	0.000734	0.107	CrCbGaD
Maprotiline—CHRM5—brain—bipolar disorder	0.000704	0.00853	CbGeAlD
Maprotiline—ORM1—nervous system—bipolar disorder	0.000678	0.00821	CbGeAlD
Maprotiline—ABCB1—blood plasma—bipolar disorder	0.000673	0.00816	CbGeAlD
Maprotiline—CHRM2—nervous system—bipolar disorder	0.000632	0.00766	CbGeAlD
Maprotiline—SLC6A3—nervous system—bipolar disorder	0.00063	0.00763	CbGeAlD
Maprotiline—CHRM3—thyroid gland—bipolar disorder	0.000612	0.00742	CbGeAlD
Maprotiline—HTR2C—nervous system—bipolar disorder	0.000609	0.00738	CbGeAlD
Maprotiline—SLC6A3—cerebellum—bipolar disorder	0.000593	0.00718	CbGeAlD
Maprotiline—CHRM1—nervous system—bipolar disorder	0.000575	0.00697	CbGeAlD
Maprotiline—CHRM3—nervous system—bipolar disorder	0.000515	0.00624	CbGeAlD
Maprotiline—SLC6A2—nervous system—bipolar disorder	0.000508	0.00616	CbGeAlD
Maprotiline—HTR7—nervous system—bipolar disorder	0.00049	0.00594	CbGeAlD
Maprotiline—CHRM2—brain—bipolar disorder	0.000483	0.00585	CbGeAlD
Maprotiline—SLC6A3—brain—bipolar disorder	0.000482	0.00584	CbGeAlD
Maprotiline—HTR2C—brain—bipolar disorder	0.000466	0.00564	CbGeAlD
Maprotiline—CYP1A2—thyroid gland—bipolar disorder	0.000465	0.00563	CbGeAlD
Maprotiline—DRD2—nervous system—bipolar disorder	0.000463	0.00561	CbGeAlD
Maprotiline—HTR7—cerebellum—bipolar disorder	0.000461	0.00559	CbGeAlD
Maprotiline—CHRM1—brain—bipolar disorder	0.00044	0.00533	CbGeAlD
Maprotiline—DRD2—cerebellum—bipolar disorder	0.000436	0.00528	CbGeAlD
Maprotiline—Protriptyline—SLC6A4—bipolar disorder	0.000422	0.0613	CrCbGaD
Maprotiline—CHRM3—brain—bipolar disorder	0.000393	0.00477	CbGeAlD
Maprotiline—SLC6A2—brain—bipolar disorder	0.000389	0.00471	CbGeAlD
Maprotiline—Metixene—HTR2C—bipolar disorder	0.00038	0.0552	CrCbGaD
Maprotiline—HTR7—brain—bipolar disorder	0.000375	0.00454	CbGeAlD
Maprotiline—HRH1—nervous system—bipolar disorder	0.000366	0.00443	CbGeAlD
Maprotiline—DRD2—brain—bipolar disorder	0.000354	0.00429	CbGeAlD
Maprotiline—ABCB1—adrenal cortex—bipolar disorder	0.000342	0.00414	CbGeAlD
Maprotiline—HTR2A—nervous system—bipolar disorder	0.000306	0.0037	CbGeAlD
Maprotiline—HTR2A—cerebellum—bipolar disorder	0.000288	0.00348	CbGeAlD
Maprotiline—HRH1—brain—bipolar disorder	0.00028	0.00339	CbGeAlD
Maprotiline—CYP2D6—nervous system—bipolar disorder	0.000278	0.00337	CbGeAlD
Maprotiline—CYP2D6—cerebellum—bipolar disorder	0.000262	0.00317	CbGeAlD
Maprotiline—Atomoxetine—SLC6A3—bipolar disorder	0.000247	0.036	CrCbGaD
Maprotiline—ABCB1—thyroid gland—bipolar disorder	0.000238	0.00288	CbGeAlD
Maprotiline—HTR2A—brain—bipolar disorder	0.000234	0.00283	CbGeAlD
Maprotiline—Atomoxetine—HTR2C—bipolar disorder	0.000223	0.0324	CrCbGaD
Maprotiline—CYP2D6—brain—bipolar disorder	0.000213	0.00258	CbGeAlD
Maprotiline—ABCB1—nervous system—bipolar disorder	0.0002	0.00243	CbGeAlD
Maprotiline—Nortriptyline—HTR2C—bipolar disorder	0.000195	0.0283	CrCbGaD
Maprotiline—Nortriptyline—HTR1A—bipolar disorder	0.000189	0.0275	CrCbGaD
Maprotiline—ABCB1—cerebellum—bipolar disorder	0.000188	0.00228	CbGeAlD
Maprotiline—Atomoxetine—SLC6A4—bipolar disorder	0.000185	0.0269	CrCbGaD
Maprotiline—Desipramine—SLC6A3—bipolar disorder	0.000178	0.0259	CrCbGaD
Maprotiline—Nortriptyline—SLC6A4—bipolar disorder	0.000162	0.0235	CrCbGaD
Maprotiline—Nortriptyline—DRD2—bipolar disorder	0.000161	0.0234	CrCbGaD
Maprotiline—Desipramine—HTR2C—bipolar disorder	0.000161	0.0233	CrCbGaD
Maprotiline—Desipramine—HTR1A—bipolar disorder	0.000156	0.0227	CrCbGaD
Maprotiline—ABCB1—brain—bipolar disorder	0.000153	0.00185	CbGeAlD
Maprotiline—Imipramine—SLC6A3—bipolar disorder	0.000151	0.0219	CrCbGaD
Maprotiline—Atomoxetine—HTR2A—bipolar disorder	0.000142	0.0207	CrCbGaD
Maprotiline—Imipramine—HTR2C—bipolar disorder	0.000136	0.0198	CrCbGaD
Maprotiline—Desipramine—SLC6A4—bipolar disorder	0.000133	0.0193	CrCbGaD
Maprotiline—Desipramine—DRD2—bipolar disorder	0.000132	0.0192	CrCbGaD
Maprotiline—Imipramine—HTR1A—bipolar disorder	0.000132	0.0192	CrCbGaD
Maprotiline—Nortriptyline—HTR2A—bipolar disorder	0.000124	0.0181	CrCbGaD
Maprotiline—Imipramine—SLC6A4—bipolar disorder	0.000113	0.0164	CrCbGaD
Maprotiline—Imipramine—DRD2—bipolar disorder	0.000112	0.0163	CrCbGaD
Maprotiline—Desipramine—HTR2A—bipolar disorder	0.000102	0.0149	CrCbGaD
Maprotiline—Imipramine—HTR2A—bipolar disorder	8.67e-05	0.0126	CrCbGaD
Maprotiline—CHRM1—Signaling Pathways—ADM—bipolar disorder	1.47e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADM—bipolar disorder	1.47e-05	0.000105	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TSHB—bipolar disorder	1.47e-05	0.000105	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PDE4B—bipolar disorder	1.47e-05	0.000105	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TACR1—bipolar disorder	1.47e-05	0.000105	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKR1C4—bipolar disorder	1.46e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADM—bipolar disorder	1.45e-05	0.000104	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.45e-05	0.000104	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TSHB—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TACR1—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADCY2—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PDE4B—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TSHB—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TACR1—bipolar disorder	1.44e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TCF7L2—bipolar disorder	1.44e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	1.44e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TSHB—bipolar disorder	1.44e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TACR1—bipolar disorder	1.44e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	1.43e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TSHB—bipolar disorder	1.43e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TACR1—bipolar disorder	1.43e-05	0.000102	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NTRK1—bipolar disorder	1.43e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DRD2—bipolar disorder	1.43e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	1.42e-05	0.000101	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TSHB—bipolar disorder	1.42e-05	0.000101	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TACR1—bipolar disorder	1.42e-05	0.000101	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—POMC—bipolar disorder	1.41e-05	0.000101	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—S100B—bipolar disorder	1.39e-05	9.91e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.38e-05	9.84e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.38e-05	9.81e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—SNAP25—bipolar disorder	1.37e-05	9.75e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.35e-05	9.66e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—POMC—bipolar disorder	1.35e-05	9.64e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NTRK1—bipolar disorder	1.35e-05	9.62e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.34e-05	9.56e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.33e-05	9.47e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	1.32e-05	9.39e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NR1D1—bipolar disorder	1.31e-05	9.36e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	1.31e-05	9.36e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—S100B—bipolar disorder	1.31e-05	9.35e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	1.31e-05	9.33e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	1.3e-05	9.24e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NTRK1—bipolar disorder	1.29e-05	9.22e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.29e-05	9.22e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.29e-05	9.18e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.28e-05	9.14e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—S100B—bipolar disorder	1.26e-05	8.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NCAN—bipolar disorder	1.26e-05	8.95e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.25e-05	8.91e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC5A3—bipolar disorder	1.23e-05	8.77e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NRG1—bipolar disorder	1.23e-05	8.74e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.22e-05	8.68e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.21e-05	8.66e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.21e-05	8.65e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ADCY2—bipolar disorder	1.21e-05	8.63e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.2e-05	8.53e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	1.2e-05	8.52e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.19e-05	8.52e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR1A—bipolar disorder	1.19e-05	8.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	1.19e-05	8.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	1.19e-05	8.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	1.19e-05	8.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	1.18e-05	8.45e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.18e-05	8.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	1.18e-05	8.39e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.18e-05	8.38e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TAC1—bipolar disorder	1.17e-05	8.37e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	1.17e-05	8.36e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.17e-05	8.36e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.17e-05	8.36e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.17e-05	8.36e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TAC1—bipolar disorder	1.17e-05	8.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TAC1—bipolar disorder	1.17e-05	8.32e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.16e-05	8.3e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NRG1—bipolar disorder	1.16e-05	8.26e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TAC1—bipolar disorder	1.15e-05	8.24e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.15e-05	8.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.15e-05	8.23e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2C—bipolar disorder	1.15e-05	8.21e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD1—bipolar disorder	1.15e-05	8.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	1.15e-05	8.18e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD1—bipolar disorder	1.15e-05	8.18e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	1.14e-05	8.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD1—bipolar disorder	1.14e-05	8.16e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK2—bipolar disorder	1.14e-05	8.13e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD3—bipolar disorder	1.14e-05	8.1e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD1—bipolar disorder	1.13e-05	8.08e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	1.13e-05	8.08e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GSK3A—bipolar disorder	1.13e-05	8.06e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.12e-05	8e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK2—bipolar disorder	1.12e-05	7.99e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.12e-05	7.97e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	1.12e-05	7.96e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD3—bipolar disorder	1.11e-05	7.95e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CLOCK—bipolar disorder	1.11e-05	7.94e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	1.11e-05	7.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.11e-05	7.93e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD3—bipolar disorder	1.11e-05	7.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GSK3A—bipolar disorder	1.11e-05	7.92e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NRG1—bipolar disorder	1.11e-05	7.91e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD3—bipolar disorder	1.11e-05	7.9e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	1.11e-05	7.89e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HTR2A—bipolar disorder	1.11e-05	7.88e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	1.1e-05	7.87e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD4—bipolar disorder	1.1e-05	7.86e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	1.1e-05	7.86e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.1e-05	7.86e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD3—bipolar disorder	1.1e-05	7.82e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	1.09e-05	7.79e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TSHB—bipolar disorder	1.09e-05	7.74e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TPH2—bipolar disorder	1.09e-05	7.74e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CACNB2—bipolar disorder	1.09e-05	7.74e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.08e-05	7.73e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD4—bipolar disorder	1.08e-05	7.72e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD4—bipolar disorder	1.08e-05	7.69e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD4—bipolar disorder	1.08e-05	7.67e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—POMC—bipolar disorder	1.07e-05	7.64e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—DPYD—bipolar disorder	1.07e-05	7.62e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD4—bipolar disorder	1.06e-05	7.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.05e-05	7.51e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.05e-05	7.51e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—POMC—bipolar disorder	1.05e-05	7.5e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.05e-05	7.49e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	1.05e-05	7.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	1.04e-05	7.45e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	1.04e-05	7.44e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.04e-05	7.4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—COMT—bipolar disorder	1.04e-05	7.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	1.03e-05	7.38e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.03e-05	7.37e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MAOA—bipolar disorder	1.03e-05	7.34e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.02e-05	7.3e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TPH2—bipolar disorder	1.02e-05	7.3e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TSHB—bipolar disorder	1.02e-05	7.3e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.02e-05	7.3e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.02e-05	7.28e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADCY2—bipolar disorder	1.02e-05	7.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.02e-05	7.26e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	1.02e-05	7.24e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	1.02e-05	7.24e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	1.01e-05	7.22e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	1.01e-05	7.22e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.01e-05	7.21e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	1.01e-05	7.19e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD2—bipolar disorder	1.01e-05	7.19e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—DPYD—bipolar disorder	1.01e-05	7.18e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD2—bipolar disorder	1e-05	7.17e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	1e-05	7.15e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD2—bipolar disorder	1e-05	7.14e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	1e-05	7.13e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	9.99e-06	7.12e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CACNA1C—bipolar disorder	9.93e-06	7.08e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD2—bipolar disorder	9.92e-06	7.07e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—POMC—bipolar disorder	9.72e-06	6.93e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3C2A—bipolar disorder	9.68e-06	6.9e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—POMC—bipolar disorder	9.57e-06	6.82e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—POMC—bipolar disorder	9.55e-06	6.81e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—POMC—bipolar disorder	9.52e-06	6.79e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—POMC—bipolar disorder	9.49e-06	6.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—POMC—bipolar disorder	9.39e-06	6.7e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CACNA1C—bipolar disorder	9.36e-06	6.67e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NTRK1—bipolar disorder	9.3e-06	6.63e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	9.15e-06	6.52e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NTRK1—bipolar disorder	9.13e-06	6.51e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	9.12e-06	6.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	9.1e-06	6.49e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	9.07e-06	6.47e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NRG1—bipolar disorder	9.04e-06	6.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—S100B—bipolar disorder	9.04e-06	6.45e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	8.98e-06	6.41e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GSK3B—bipolar disorder	8.9e-06	6.35e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CLOCK—bipolar disorder	8.89e-06	6.34e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—S100B—bipolar disorder	8.89e-06	6.34e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—S100B—bipolar disorder	8.87e-06	6.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—S100B—bipolar disorder	8.84e-06	6.31e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—POMC—bipolar disorder	8.83e-06	6.3e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—S100B—bipolar disorder	8.82e-06	6.29e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—INS—bipolar disorder	8.78e-06	6.26e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—S100B—bipolar disorder	8.73e-06	6.23e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SNAP25—bipolar disorder	8.68e-06	6.19e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TSHB—bipolar disorder	8.67e-06	6.18e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CACNB2—bipolar disorder	8.67e-06	6.18e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TPH2—bipolar disorder	8.67e-06	6.18e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—DPYD—bipolar disorder	8.53e-06	6.08e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	8.4e-06	5.99e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MTHFR—bipolar disorder	8.38e-06	5.98e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—POMC—bipolar disorder	8.34e-06	5.95e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—INS—bipolar disorder	8.29e-06	5.91e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SNAP25—bipolar disorder	8.18e-06	5.83e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	8.15e-06	5.81e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	8.05e-06	5.74e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—bipolar disorder	7.98e-06	5.69e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NRG1—bipolar disorder	7.98e-06	5.69e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—INS—bipolar disorder	7.94e-06	5.66e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CACNA1C—bipolar disorder	7.93e-06	5.65e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NRG1—bipolar disorder	7.85e-06	5.6e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NRG1—bipolar disorder	7.83e-06	5.59e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NRG1—bipolar disorder	7.81e-06	5.57e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NRG1—bipolar disorder	7.78e-06	5.55e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	7.72e-06	5.51e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NRG1—bipolar disorder	7.71e-06	5.5e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ADCY2—bipolar disorder	7.68e-06	5.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.62e-06	5.44e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ADCY2—bipolar disorder	7.24e-06	5.16e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—bipolar disorder	7.19e-06	5.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—bipolar disorder	7.06e-06	5.04e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	7.04e-06	5.02e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	7.02e-06	5e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	6.95e-06	4.96e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SNAP25—bipolar disorder	6.93e-06	4.94e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—bipolar disorder	6.7e-06	4.78e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—INS—bipolar disorder	6.66e-06	4.75e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—COMT—bipolar disorder	6.58e-06	4.69e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	6.56e-06	4.68e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MAOA—bipolar disorder	6.53e-06	4.66e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—bipolar disorder	6.51e-06	4.64e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—INS—bipolar disorder	6.47e-06	4.62e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—COMT—bipolar disorder	6.2e-06	4.42e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MAOA—bipolar disorder	6.15e-06	4.39e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ADCY2—bipolar disorder	6.13e-06	4.37e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GSK3B—bipolar disorder	5.79e-06	4.13e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—bipolar disorder	5.74e-06	4.1e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INS—bipolar disorder	5.71e-06	4.07e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	5.7e-06	4.06e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GSK3B—bipolar disorder	5.68e-06	4.05e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	5.67e-06	4.04e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—bipolar disorder	5.65e-06	4.03e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	5.65e-06	4.03e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—bipolar disorder	5.64e-06	4.02e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—bipolar disorder	5.62e-06	4.01e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INS—bipolar disorder	5.62e-06	4.01e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INS—bipolar disorder	5.61e-06	4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—bipolar disorder	5.6e-06	4e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	5.59e-06	3.99e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INS—bipolar disorder	5.59e-06	3.99e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INS—bipolar disorder	5.57e-06	3.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—bipolar disorder	5.55e-06	3.96e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—bipolar disorder	5.52e-06	3.94e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—bipolar disorder	5.32e-06	3.79e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—COMT—bipolar disorder	5.25e-06	3.74e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MAOA—bipolar disorder	5.21e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.01e-06	3.57e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—bipolar disorder	4.25e-06	3.03e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—bipolar disorder	4.24e-06	3.03e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—bipolar disorder	4.23e-06	3.02e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—bipolar disorder	4.01e-06	2.86e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—bipolar disorder	3.98e-06	2.84e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—bipolar disorder	3.39e-06	2.42e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—bipolar disorder	3.38e-06	2.41e-05	CbGpPWpGaD
